Koert M. Dolman

Koert M. Dolman

Auto-generated profile, based on publicly available information

Koert M. Dolman

Sint Lucas Andreas Hospital and Reade location Jan van Breemen, Amsterdam, The Netherlands.

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2015 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JAJanneke Anink
Janneke Anink
LSLisette W. A. Van Suijlekom-Smit
Lisette W. A. Van Suijlekom-Smit
MOMarieke H. Otten
Marieke H. Otten
FPFemke H. M. Prince
Femke H. M. Prince
MRMarion A. J. van Rossum
Marion A. J. van Rossum
DHDirk Holzinger
Dirk Holzinger
Introduction: Approximately 30 % of juvenile idiopathic arthritis (JIA) patients fail to respond to anti-TNF treatment. When clinical remission is induced, some patients relapse after treatment has been stopped. We tested the predictive value of MRP8/14 serum levels to identify responders to treatment and relapse after discontinuation of therapy. Methods: Samples from 88 non-systemic JIA patients who started and 26 patients who discontinued TNF-blockers were analyzed. MRP8/14 serum levels were measured by in-house MRP8/14 ELISA and by Bühlmann Calprotectin ELISA at start of anti-TNF treatment, within 6 months after start and at discontinuation of etanercept in clinical remission. Patients were categorized into responders (ACRpedi ≥ 50 and/or inactive disease) and non-responders (ACRpedi < 50) within six months after start, response was evaluated by change in JADAS-10. Disease activity was assessed within six months after discontinuation. Results: Baseline MRP8/14 levels were higher in responders (median MRP8/14 of 1466 ng/ml (IQR 1045–3170)) compared to non-responders (median MRP8/14 of 812 (IQR 570–1178), p < 0.001). Levels decreased after start of treatment only in responders (p < 0.001). Change in JADAS-10 was correlated with baseline MRP8/14 levels (Spearman’s rho 0.361, p = 0.001). Patients who flared within 6 months after treatment discontinuation had higher MRP8/14 levels (p = 0.031, median 1025 ng/ml (IQR 588–1288)) compared to patients with stable remission (505 ng/ml (IQR 346–778)). Results were confirmed by Bühlmann ELISA with high reproducibility but different overall levels. Conclusion: High levels of baseline MRP8/14 are associated with good response to anti-TNF treatment, whereas elevated MRP8/14 levels at discontinuation of etanercept are associated with higher chance to flare.

1 May 2014 in American Journal of Roentgenology
Verified
Journal Article
Closed access
CNCharlotte M Nusman
Charlotte M Nusman
RHRobert Hemke
Robert Hemke
DSDieneke Schonenberg
Dieneke Schonenberg
KDKoert M. Dolman
Koert M. Dolman
MRMarion A.J. van Rossum
Marion A.J. van Rossum
MMMario Maas
Mario Maas
The aim of this study in clinically active juvenile idiopathic arthritis (JIA) was to assess the frequency and distribution pattern of synovitis as hallmark of disease and additional soft-tissue and bony abnormalities on MRI in the knee and wrist as two target joints. MRI datasets of 153 clinically active JIA patients (110 with knee and 43 with wrist involvement) were evaluated independently by two readers for the presence of literature-based imaging features: "synovial hypertrophy," "bone marrow changes," "bone erosions," "tenosynovitis" (only in the wrist), and "cartilage lesions" (only in the knee) in accordance with validated definitions and scoring locations. Synovial hypertrophy was most frequently observed--both in the knee and in the wrist (61.8-65.1% of cases). For the knee, the most frequently involved locations were the cruciate ligaments (46/183 locations [25.1%] affected with synovial hypertrophy) and medial patella (18/62 locations [29.0%] with bone marrow changes). Cartilage lesions and bone erosions were rare (5.5-7.3% of cases). For the wrist, most frequently involved were the radiocarpal joint (21/64 locations [32.8%] with synovial hypertrophy), lunate (7/46 locations [15.2%] with bone marrow changes), and capitate or triquetrum (6/28 locations [21.4%] with bone erosions). Tenosynovitis was a common wrist-specific feature (46.5% of cases). MRI showed no abnormalities in a subgroup of patients with clinically active knee (23.6%) and wrist (16.3%) involvement. The distribution pattern of MRI abnormalities in the knee and wrist of active JIA patients provides a practical tool to detect a signature of JIA disease activity in target joint

17 December 2012
Verified
Journal Article
Closed access
JAJanneke Anink
Janneke Anink
KDKoert M Dolman
Koert M Dolman
JBJ.Merlijn van Den Berg
J.Merlijn van Den Berg
MVMira Van Veenendaal
Mira Van Veenendaal
TKTaco W. Kuijpers
Taco W. Kuijpers
MRMarion A J Van Rossum
Marion A J Van Rossum